Milestone Scientific holders elect five directors, approve authorized share increase
At its July 27, 2026 annual meeting, Milestone Scientific stockholders re-elected five directors, approved raising authorized common stock from 125,000,000 to 135,000,000 shares, and approved increasing the share reserve under its 2020 Equity Incentive Plan from 11,500,000 to 28,750,000 shares. A larger pool of authorized and plan shares gives the company room to issue more stock in the future. The board also re-elected Kelly Ulto and Greg Shilling as directors and named them to committee roles.
Key points
- Stockholders approved the authorized share increase with 22,541,526 shares for and 795,607 against, or 96.59% of votes cast.
- Stockholders approved the equity plan increase with 18,716,361 shares for and 4,440,070 against, or 80.82% of votes cast.
- Kelly Ulto was named Audit Committee chair and Greg Shilling was named Compensation Committee chair, effective with the July 2026 board action.
- Shares voted totaled 44,335,594, representing 50.12% of the 88,449,412 shares outstanding at the record date.
The filing
Written by AI on Nov 9, 2026, 8:29 AM ET, from this filing only. Written later: this filing was briefed after the fact, when past filings were added to the site, so the brief may be read with hindsight; the filing itself is the record of what was known on July 31, 2026.
Briefs are written by AI from the filing text and can contain mistakes — open the filing before acting on anything. Impact (1-5) and tone are the AI's reading of the filing for shareholders, not a price forecast. Not investment advice.